Filter
2143
Filtered Results: 2143
Text search:
infect
drug
use
Featured
Recommendations
218
New Publications
475
Language
Document type
No document type
1226
Studies & Reports
357
Guidelines
327
Manuals
88
Strategic & Response Plan
55
Fact sheets
38
Training Material
28
Infographics
9
Situation Updates
8
Brochures
4
Resource Platforms
3
Countries / Regions
India
88
Global
55
Kenya
54
South Africa
53
Western and Central Europe
49
Tanzania
46
Nepal
44
Ukraine
37
Latin America and the Carribbean
32
Eastern Europe
30
Ethiopia
29
Nigeria
28
Russia
27
Myanmar / Burma
27
Asia
26
Uganda
26
Africa
24
Zambia
24
Brazil
23
Sierra Leone
22
Malawi
19
Liberia
19
Ghana
18
Namibia
18
Bangladesh
17
Philippines
16
Germany
13
South–East Asia Region
13
Rwanda
12
Mozambique
12
Colombia
10
Albania
9
Senegal
9
Indonesia
9
Lesotho
8
Cambodia
8
Tajikistan
7
Burkina Faso
7
Congo, Democratic Republic of
7
Georgia
7
Zimbabwe
6
Armenia
6
West and Central Africa
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Botswana
6
Cameroon
5
Venezuela
5
East and Southern Africa
5
Argentina
5
Moldova
5
South Sudan
5
Eswatini/ Swaziland
5
Pakistan
5
North Macedonia
4
Thailand
4
Syria
4
Estonia
4
Peru
4
Benin
3
China
3
USA
3
Haiti
3
Guinea-Bissau
3
Paraguay
3
North America
3
Bolivia
3
Vietnam
3
Yemen
3
Mali
3
Angola
3
Mexico
2
Serbia
2
Turkey
2
Laos
2
Guinea
2
Jordan
2
Uruguay
2
France
2
Spain
2
Papua New Guinea
2
Sri Lanka
2
Sudan
2
Honduras
2
Ecuador
2
Switzerland
1
Timor Leste/ East Timor
1
El Salvador
1
Gambia
1
Kazakhstan
1
Canada
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Afghanistan
1
Western Pacific Region
1
Jamaica
1
Belgium
1
United Kingdom
1
Portugal
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Egypt
1
Romania
1
Poland
1
Chad
1
Libya
1
Bhutan
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
641
Clinical Guidelines
231
Public Health
71
Women & Child Health
52
Key Resources
35
Pharmacy & Technologies
27
Capacity Building
24
Toolboxes
HIV
497
TB
284
NTDs
138
COVID-19
129
AMR
118
Mental Health
79
Rapid Response
46
Malaria
38
Pharmacy
37
Ebola & Marburg
35
Refugee
33
Caregiver
27
Planetary Health
27
NCDs
16
Health Financing Toolbox
13
Zika
12
Polio
12
Global Health Education
11
Conflict
10
Cholera
7
Specific Hazards
5
Natural Hazards
4
Disability
3
Social Ethics
2
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
HIV infection, due to the immunosuppressant that leads, nowadays constitutes an aggravating factor of endemic tuberculosis. Tuberculosis remains a huge burden to human health, even in the early 21st century. The situation is deteriorating in many countries, particularly because of the synergy with t...
Tsetse traps and targets (insecticide-impregnated screens) function by attracting the flies to a device that collects and/or kills them. Traps can be used for entomological surveillance, and also for control. Targets are simpler than traps, but are not used for surveillance. They are impregnated wit...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Tropical Medicine and Infectious Disease 2017, 2(4), 50
This is a cross-sectional analysis of baseline data in a longitudinal study on asymptomatic, LF antigen-positive and -negative young people in Myanmar. Rapid field screening was used to identify antigen-positive cases and a group of antige...
This is a cross-sectional analysis of baseline data in a longitudinal study on asymptomatic, LF antigen-positive and -negative young people in Myanmar. Rapid field screening was used to identify antigen-positive cases and a group of antige...
This regional advocacy strategy on HIV and AIDS, tuberculosis (TB) and sexually transmitted infetions (STIs) is intended for use by Southern African Development Community (SADC) Member States at a national level. This is an overall advocacy strategy highlighting the most important issues relating to...
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
Accessed: 10.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
The purpose of this guide is to provide updated clinical guidance on TB/HIV, with an emphasis on diagnostic aspects—including new techniques—as well as current treatment, while maintaining a public health approach. By compiling and consolidating the latest World Health Organization recommendatio...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide te...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
